We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Insight Enterprises
NSIT
$4.6B
| $1.04M | ﹤0.01% |
6,830
| – | – |
|
952
EnerSys
ENS
$7.2B
| $1.04M | ﹤0.01% |
11,230
| – | – |
|
953
FirstCash
FCFS
$9.14B
| $1.04M | ﹤0.01% |
10,016
+500
| +5% | +$53.9K |
|
954
Veracyte
VCYT
$3.42B
| $1.04M | ﹤0.01% |
26,206
-1,200
| -4% | -$45.4K |
|
955
Dillards
DDS
$9.59B
| $1.04M | ﹤0.01% |
2,400
-100
| -4% | -$41K |
|
956
Enpro
NPO
$7.12B
| $1.03M | ﹤0.01% |
6,000
+1,400
| +30% | +$237K |
|
957
Ashland
ASH
$3.36B
| $1.02M | ﹤0.01% |
14,300
+1,600
| +13% | +$128K |
|
|
GMS
958
DELISTED
GMS Inc
GMS
| $1.01M | ﹤0.01% |
11,937
+2,500
| +26% | +$235K |
|
959
Joby Aviation
JOBY
$8.17B
| $1.01M | ﹤0.01% |
124,100
+22,400
| +22% | +$149K |
|
960
Option Care Health
OPCH
$3.61B
| $1.01M | ﹤0.01% |
43,400
-4,400
| -9% | -$111K |
|
961
Acadia Pharmaceuticals
ACAD
$4.89B
| $1.01M | ﹤0.01% |
54,833
+7,200
| +15% | +$116K |
|
962
Littelfuse
LFUS
$11.4B
| $1M | ﹤0.01% |
4,265
-500
| -10% | -$125K |
|
963
Box
BOX
$4.66B
| $1M | ﹤0.01% |
31,753
-8,100
| -20% | -$266K |
|
964
Yeti Holdings
YETI
$3.44B
| $1M | ﹤0.01% |
26,000
-3,900
| -13% | -$155K |
|
965
Axsome Therapeutics
AXSM
$11.2B
| $998K | ﹤0.01% |
11,800
-500
| -4% | -$46K |
|
966
Cabot Corp
CBT
$4.45B
| $996K | ﹤0.01% |
10,909
+2,000
| +22% | +$215K |
|
967
First Financial Bankshares
FFIN
$5.04B
| $996K | ﹤0.01% |
27,618
| – | – |
|
968
Blackstone Mortgage Trust
BXMT
$2.44B
| $993K | ﹤0.01% |
57,051
+8,500
| +18% | +$157K |
|
969
Signet Jewelers
SIG
$3.6B
| $993K | ﹤0.01% |
12,300
-100
| -0.8% | -$9.31K |
|
970
Westlake Corp
WLK
$10.2B
| $986K | ﹤0.01% |
8,600
-1,700
| -17% | -$221K |
|
|
SFBS
971
ServisFirst Bancshares
SFBS
$5B
| $985K | ﹤0.01% |
11,623
+1,100
| +10% | +$97.7K |
|
972
Pegasystems
PEGA
$5.51B
| $983K | ﹤0.01% |
21,088
| – | – |
|
973
National Health Investors
NHI
$3.5B
| $981K | ﹤0.01% |
14,151
| – | – |
|
974
Macy's
M
$6.27B
| $980K | ﹤0.01% |
57,865
| – | – |
|
975
Brink's
BCO
$4.72B
| $978K | ﹤0.01% |
10,537
+1,400
| +15% | +$140K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.